
As 2023 ends and 2024 approaches, we are thankful for a year dedicated to new therapeutics for patients in need, and we look forward to a new year of continued innovations.

Mike Hennessy Jr, is the Chief Executive Officer and Chairman of MJH Life Sciences.

As 2023 ends and 2024 approaches, we are thankful for a year dedicated to new therapeutics for patients in need, and we look forward to a new year of continued innovations.

2023 has been complete with numerous innovations in the dermatology space, including in atopic dermatitis, psoriasis, alopecia areata, and more.

The October issue of Dermatology Times spotlights numerous awareness campaigns and their impact on improving and enhancing patient care.

Discover how we continue to spotlight innovation and remain curious with the goal to help you improve patient outcomes.

Back-to-school season is an opportunity for dermatology clinicians to empower pediatric, adolescent, and young adult patients with treatment solutions for diagnoses including acne, atopic dermatitis, and skin cancer.

Nurse practitioners and physician assistants play a crucial role in dermatology, and Dermatology Times is proud to curate content embracing and empowering the NP/PA community.

The research delving into skin conditions affecting patients with skin of color, patients in the LGBTQIA+ community, and patients requiring multidisciplinary treatment continues to grow.

Clinicians who provide dermatologic care know firsthand how diseases of the skin can diminish someone’s confidence and productivity.


Conferences provide valuable information and resources to help you grow in the dermatology space.

It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.